Skip to main content
Premium Trial:

Request an Annual Quote

Celera Reveals Sequencing Status, Says it Has 97 Percent of Human Genes



OCKVILLE, Md.--Craig Venter grabbed news headlines last week when he held a press conference here to announce that his company, Celera Genomics, has sequenced 90 percent of human DNA, an amount that the company estimated covers 97 percent of all human genes. Since it began work on the human genome in early September, Celera has sequenced more than 5 billion base pairs of the human genome, including 2.58 billion base pairs of unique sequence. For the next several months, the company expects to add 2 billion base pairs per month. The data will ultimately be available by subscription to academic and commercial institutions, the company said. The New York Times reported that Celera’s pharmaceutical company subscribers pay $50 million per year for database access.

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.